Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 20, 2022
Non-selective beta-blockers in patients with ascites: The complex interplay among the liver, kidney and heart
Luis Téllez, Agustín Albillos
Clinical Drug Investigation
|
May 6, 2022
Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications)
Luis Téllez, Antonio Guerrero
Medicina Clinica
|
February 1, 2024
[Portosinusoidal vascular disorder: A paradigm shift]
Luis Téllez, Jesús Donate, Agustín Albillos
Hepatology (Baltimore, Md.)
|
October 17, 2015
Continued controversy over the safety of beta-blockers in decompensated cirrhosis
Agustín Albillos, Javier Martínez, Luis Téllez
Gastroenterologia Y Hepatologia
|
July 31, 2020
COVID-19 and liver disease: An update
Luis Téllez, Rosa María Martín Mateos
Journal of Hepatology
|
June 10, 2023
Reply to: "Anticoagulation to prevent disease progression in patients with cirrhosis"
Agustín Albillos, Antonio Guerrero, Luis Téllez
Revista Espanola De Enfermedades Digestivas
|
May 24, 2014
[Non cirrhotic portal hypertension]
Luis Téllez-Villajos, Agustín Albillos-Martínez
Revista Espanola De Enfermedades Digestivas
|
August 26, 2022
Update on the diagnosis and management of portal hypertension in cirrhosis according to the Baveno VII Consensus Conference recommendations
Luis Téllez, Antonio Guerrero, Agustín Albillos
Journal of Hepatology
|
February 19, 2026
Early portopulmonary hypertension: a signal of increased mortality risk in cirrhosis
Luis Téllez, Jesús Donate, Agustín Albillos
Journal of Hepatology
|
December 14, 2020
Reply to: "Open or closed window: That is the question"
Luis Téllez, Rafael Bañares, Agustín Albillos
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 20, 2022
Non-selective beta-blockers in patients with ascites: The complex interplay among the liver, kidney and heart
Luis Téllez, Agustín Albillos
Clinical Drug Investigation
|
May 6, 2022
Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications)
Luis Téllez, Antonio Guerrero
Medicina Clinica
|
February 1, 2024
[Portosinusoidal vascular disorder: A paradigm shift]
Luis Téllez, Jesús Donate, Agustín Albillos
Hepatology (Baltimore, Md.)
|
October 17, 2015
Continued controversy over the safety of beta-blockers in decompensated cirrhosis
Agustín Albillos, Javier Martínez, Luis Téllez
Gastroenterologia Y Hepatologia
|
July 31, 2020
COVID-19 and liver disease: An update
Luis Téllez, Rosa María Martín Mateos
Journal of Hepatology
|
June 10, 2023
Reply to: "Anticoagulation to prevent disease progression in patients with cirrhosis"
Agustín Albillos, Antonio Guerrero, Luis Téllez
Revista Espanola De Enfermedades Digestivas
|
May 24, 2014
[Non cirrhotic portal hypertension]
Luis Téllez-Villajos, Agustín Albillos-Martínez
Revista Espanola De Enfermedades Digestivas
|
August 26, 2022
Update on the diagnosis and management of portal hypertension in cirrhosis according to the Baveno VII Consensus Conference recommendations
Luis Téllez, Antonio Guerrero, Agustín Albillos
Journal of Hepatology
|
February 19, 2026
Early portopulmonary hypertension: a signal of increased mortality risk in cirrhosis
Luis Téllez, Jesús Donate, Agustín Albillos
Journal of Hepatology
|
December 14, 2020
Reply to: "Open or closed window: That is the question"
Luis Téllez, Rafael Bañares, Agustín Albillos
Page
of 9